Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxShares Outstanding (Weighted Average)
Others
Ratios

Genprex (GNPX) Research & Development (2016 - 2024)

Genprex (GNPX) has 9 years of Research & Development data on record, last reported at $2.2 million in Q3 2025.

  • For Q3 2025, Research & Development fell 20.43% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $10.1 million, down 11.74%, while the annual FY2024 figure was $10.5 million, 40.2% down from the prior year.
  • Research & Development reached $2.2 million in Q3 2025 per GNPX's latest filing, down from $2.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $5.3 million in Q1 2023 and bottomed at $1.4 million in Q3 2021.
  • Average Research & Development over 5 years is $2.9 million, with a median of $2.8 million recorded in 2024.
  • Peak YoY movement for Research & Development: surged 160.27% in 2023, then tumbled 58.1% in 2024.
  • A 5-year view of Research & Development shows it stood at $3.8 million in 2021, then fell by 11.92% to $3.4 million in 2022, then grew by 9.68% to $3.7 million in 2023, then fell by 23.55% to $2.8 million in 2024, then dropped by 22.74% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $2.2 million in Q3 2025, $2.5 million in Q2 2025, and $2.5 million in Q1 2025.